Gambro accused of inflating dialysis pricing in US
This article was originally published in Clinica
Executive Summary
Swedish company Gambro's US subsidiary, Gambro Healthcare, has been accused of grossly inflating prices for dialysis services at clinics in areas in the US where it dominates the dialysis business.